Page 3 - Best Sarcoma doctors: TOP 107 doctors

Dr. Dror Levin specializes in sarcoma treatment for children at Sourasky Medical Center – one of Israel's leading hospitals.

• Director of pediatric hematology oncology at Sourasky
• Trained at Rizzoli Orthopaedic Institute – a global leader in sarcoma care
• Coordinates sarcoma treatment with oncology-orthopedic specialists
• Member of ISPHO – Israel's pediatric hemato-oncology association

Dr. Yildiz has authored 17+ peer-reviewed publications on rare cancer cases, including sarcoma-related research at Medipol Mega University Hospital.

• Expertise in neuroendocrine tumors and rare oncological conditions
• Published on paraneoplastic syndromes and metastatic cancers
• Special focus on complex diagnostic presentations
• Active researcher in multidisciplinary cancer management

Dr. Amir specializes in treating complex sarcomas, including osteosarcoma and Ewing's sarcoma, with a strong military medicine background.

• Awarded multiple grants for excellence in surgical oncology
• Member of prestigious societies like the American Musculoskeletal Tumor Society
• Trained in orthopaedic oncology at the National Cancer Institute, USA
• Specializes in limb salvage techniques
• Recipient of the Tannenbaum Grant for Excellence in Surgical Oncology

He leads the Metastatic Bone Lesions Department at Ichilov Medical Center (Sourasky) and treats sarcoma cases there.

• Specializes in oncological orthopedics, the field of bone cancer surgery.
• Professor at Tel Aviv University's Faculty of Medicine – trains future surgeons.
• Senior Doctor at a major Israeli oncology center with international internship experience.

Univ. Prof. Dr. Wolfgang Köstler is a distinguished Austrian medical oncologist specializing in breast and gynecologic cancers, with over two decades of experience in targeted therapies.

• Associate Professor at the Medical University of Vienna
• Deputy Head of the Clinical Division of Oncology
• Expert in biomarker development and tumor biology
• Senior consultant at Wiener Privatklinik

Associate Professor Tahsin Ozatli specializes in breast, lung, and gastrointestinal cancers at Istinye Liv University Hospital.

• Internal Medicine Specialist with extensive oncology experience
• Practiced at Ankara Oncology Clinic and Erzurum Regional Training Hospital
• Promoted to Associate Professor in 2016
• Graduated from Selcuk University Faculty of Medicine

Dr. Acikgoz has performed 900+ sarcoma procedures and participated in groundbreaking immuno-oncology trials at Ohio State University.

• 10 years of experience of experience specializing in sarcoma treatments
• Assistant investigator in Phase III clinical trials, including CheckMate-649
• Trained at prestigious institutions like Ohio State University
• Member of ASCO and Turkish Society of Medical Oncology

Dr. Alemdar specializes in sarcoma treatment with extensive training in medical oncology at Akdeniz University.

• Board-certified in medical oncology since 2018
• Over 20 years of experience of experience in oncology
• Worked at Akdeniz University Hospital – a leading oncology center
• Member of the Turkish Medical Oncology Association

Assoc. Prof. Nail Paksoy specializes in sarcoma treatment at Medipol Bahçelievler Hospital, with extensive research published on high-dose chemotherapy for Ewing's Sarcoma.

• ESMO Board Certified in Medical Oncology
• Published multiple studies on sarcoma treatments
• Active participant in international clinical trials
• Fellowship-trained at Istanbul University Oncology Institute

Dr. Irfan Cicin is a Professor of Medical Oncology at the Trakya University Faculty of Medicine (2015–present). He has over 20 years of medical oncology experience and has held academic roles since 2010.

Education: MD, Istanbul University – Cerrahpaşa (1991–1997). Residency in Internal Medicine, Trakya University (1997–2002). Fellowship in Medical Oncology, Trakya University (2002–2004).

Practice: Medical Oncologist, Trakya University (2005–2008). Medical Oncologist, Elazığ Training and Research Hospital (2008–2010). Associate Professor of Medical Oncology, Trakya University (2010–2015). He previously served as a physician in the Turkish Air Force at Etimesgut Military Hospital (2004–2005).

Prof. Zvi Cohen is Director of the Neurosurgery Department and the Neuro-Oncology Unit at Sheba Medical Center. He is a neurosurgeon and neuro-oncology expert. He was included in Forbes Israel’s Best Doctors 2025. He leads clinical research on drug therapies for malignant brain tumors. He also founded Sheba’s brain tumor tissue bank.

He is board-certified in neurosurgery. He trained at Tel Aviv University. He completed fellowships in neuroradiology at Beth Israel and in neurosurgical oncology at MD Anderson. His practice covers complex brain, pituitary, spine, and spinal cord tumors. He has expertise in stereotactic biopsies, image-guided resections, intraoperative MRI, navigation systems, and radiosurgery. He is a member of the Society for Neuro-Oncology and the Israeli Association of Neurological Surgeons.

Assoc. Prof. Atakan Topçu, M.D., is a medical oncologist at Medipol University and Medipol Acıbadem Regional Hospital. He treats solid tumors, including lung, breast, colorectal, gastric, and neuroendocrine cancers. His work also covers targeted therapies, immunotherapy, geriatric oncology, and cancer-related malnutrition, cachexia, and sarcopenia.

He has authored more than 50 peer-reviewed papers. Recent work includes a 2024 Frontiers in Medicine study on geriatric syndromes and a 2023 Future Oncology paper on sarcopenia and anxiety in lung cancer. He has also published on the CONUT score in breast cancer and on malnutrition in HER2-negative metastatic gastric cancer.

Dr. Topçu serves on the Editorial Board of BMC Cancer. He is a member of the Turkish Society of Medical Oncology, ESMO, and the Turkish Geriatrics Society. Education and training: M.D., Uludağ University; residency in Internal Medicine, Marmara University; fellowship in Medical Oncology, Bezmialem Vakıf University.

49 years of experience specializing in virotherapy – Dr. Jaunalksne leads Pallas Clinic's cutting-edge sarcoma treatments using the latest immunological approaches.

• Head of Clinical Immunology Center at Pauls Stradins Clinical University Hospital
• Graduate of Riga Medical Institute with internship in Internal Medicine
• Pioneering immunology techniques for complex sarcoma cases

Dr. Mariam Mohammed Hussein Abu Zeid is a clinical oncologist. She treats solid tumors and hematologic cancers. She earned her MBBCh from Ain Shams University in 2007 (Excellent). She completed a Master’s in Clinical Oncology and Nuclear Medicine in 2011 (Very Good). She received a Ph.D. in 2018 and an ESMO Certificate in 2015.

She leads and monitors clinical trials. Her work includes data collection and analysis. She administers chemotherapy and manages treatment toxicities. She also plans care with multidisciplinary teams. Her experience includes Ain Shams University Hospitals (2009–2012), the International Medical Center (2012–2014), and Wadi El Nile Hospital (2015–2019). Her roles covered diagnosis and staging, supportive care, quality improvement, and screening. She educates patients and families about the diagnosis, treatment options, and palliative care.

Dr. Emad Shash, M.B.B.Ch, MSc, M.D., is a medical oncologist. He is the Medical Director of the Breast Comprehensive Cancer Hospital at NCI. He leads the Medical Oncology Department and is the Breast Program Director at Shifaa Al Orman Cancer Hospital in Luxor. His clinical focus includes breast, gynecologic, genitourinary, thoracic, gastrointestinal, and rare cancers. He specializes in systemic therapy, including chemotherapy, targeted therapy, and immunotherapy.

He served as coordinating research physician and medical lead at the EORTC from 2011 to 2015. Since 2008, he has contributed to more than 70 international oncology trials as a coordinator, sub-investigator, principal investigator, and sponsor medical monitor. Credentials include M.B.B.Ch (2004), MSc (2010), MD (2015), and the EORTC Certificate of Excellence (2015). He also holds a Diploma in Hospital Quality Management & Patient Safety (JCI/57357, 2017). He is a Fellow of the EIO. He is a member of ESMO (panel voting), ESGO, and ASCO (IAC), and serves on the ECRIN board.

Dr. Maha Yahia is a medical oncologist and hemato-oncologist. She provides assessment, diagnosis, and treatment planning. Her treatments include chemotherapy, targeted therapy, and immunotherapy. She cares for patients with breast, genitourinary, gynecologic, thoracic, gastrointestinal, and rare cancers.

Education: M.B.B.Ch, Kasr El-Aini, Cairo University (1997–2003). Master in Hemato-oncology, National Cancer Institute, Cairo University (2008). Doctoral Degree in Hemato-oncology, National Cancer Institute, Cairo University (2015).

Experience: Resident in Medical Oncology, Maadi AFMC (2005–2010). Visitor Resident, NCI Cairo (2008–2009). Consultant Assistant, Prof. Hussein Khaled Clinic (2010–2017). Specialist, International Medical Center (2011–2012), Wadi El Nile Hospital (2013–2014), and Maadi AFMC (2011–2018). Head, Clinical Research Support Team, Maadi AFMC (2016–2018). Major (2014–2016) and Lt. Colonel Doctor (2016–2018), Egyptian Armed Forces. Lecturer of Clinical Research, AFCM (2019–2021).

Dr. Arslan specializes in sarcomas at Medicalpoint International Hospital, with training from Hacettepe University – a leading oncology center.

• Medical oncology specialist with focus on rare cancers
• Trained at Hacettepe University's renowned oncology department
• Full member of ESMO and Turkish Medical Oncology Association
• Experience treating various complex cancers including sarcomas

Professor Raanan Berger, MD PhD, is a medical oncologist and radiotherapist. He is Director of the Cancer Center at Sheba Medical Center and heads its clinical research unit. He was listed in Forbes Israel’s “Best Doctors” (2025). He leads the genitourinary oncology program with a focus on prostate cancer. His care includes systemic therapy and radiotherapy in a multidisciplinary, patient-centered model.

He is board-certified in oncology. He earned his MD and PhD at Tel Aviv University and completed his clinical training at Sheba. He then completed a postdoctoral fellowship at Dana-Farber/Harvard, focusing on prostate cancer with Dr. Philip Kantoff and molecular oncology in Dr. William C. Hahn’s lab. He is a member of ESMO and ASCO. He has co-authored more than 20 peer-reviewed papers, including studies on outcomes in high- versus very high-risk prostate cancer and on BRCA1/2 in large cohorts.

Dr. Muhammed Mustafa Atci is an Associate Professor of Medical Oncology at İstinye University, Liv Hospital Topkapı (2025–present). He previously served as Associate Professor and Education Coordinator at Prof. Dr. Cemil Taşcıoğlu City Hospital (2023–2025). He was also a Medical Oncologist there (2018–2021).

He has been a member of ASCO and the Turkish Society of Medical Oncology since 2018. He is the author or co-author of 19 peer-reviewed international papers on colon, breast, gastric, pancreatic, lung, thyroid, sarcoma, and colorectal cancers.

Notable works include a multicentre study on stage IIB colon cancer survival (Journal of Chemotherapy). He also studied the De Ritis ratio for lung metastasis in testicular cancer (Current Urology). His prognostic studies used PET/CT, MSI, lymph node ratio, and metabolic tumor volume.